Study finds doctors prescribing more sedatives

Study finds doctors prescribing more sedatives
Frequent use of these powerful drugs along with narcotic painkillers may explain more medication deaths.

(HealthDay)—Doctors in the United States are writing more prescriptions for sedatives than ever before, and the frequent use of these powerful drugs in combination with narcotic painkillers may be causing medication-related deaths, a new study suggests.

Sedatives are used to treat problems such as anxiety, mood disorders and insomnia, and include drugs such as Valium, Halcion, Xanax, Ativan and Librium.

For the study, researchers looked at 3.1 billion visits made by Americans between 2002 and 2009, and found that 12.6 percent of those visits involved prescriptions for sedatives (benzodiazepines) or narcotic (opioid) painkillers. They also found that the number of prescriptions for sedatives increased 12.5 percent a year.

Patients who received narcotic painkiller prescriptions were 4.2 times more likely to also have sedative prescriptions, and the number of joint of opioids and benzodiazepines rose 12 percent a year, the Stanford University researchers said.

Their findings were presented March 6 at the annual meeting of the American Academy of Pain Medicine, in Phoenix, Ariz. Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.

"More research is needed to [identify] the reason behind the increase in benzodiazepine prescription, and a national effort is needed to highlight the danger of co-prescription of benzodiazepines and opioids," study principal investigator Dr. Sean Mackey, director of the Stanford Systems Neuroscience and Pain Lab, said in a pain academy news release.

The study showed that the use of sedatives and narcotic painkillers contribute to at least 30 percent of narcotic painkiller-related deaths, according to the investigators. They also noted there are a number of risks associated with sedative use, including falls in older people, emergency department visits and drug dependence.

Doctors need to be better educated about the risks of combining the two medications, and there needs to be better coordination between those who prescribe (often primary care doctors or pain specialists) and those who prescribe (often primary care doctors or psychiatrists), said study co-author Dr. Ming-Chih Kao, a clinical assistant professor at Stanford University Medical Center, in California.

More information: The Center for Substance Abuse Research at the University of Maryland has more about sedatives.

add to favorites email to friend print save as pdf

Related Stories

Study: Friends common source of abused meds

Mar 04, 2014

Most people who abuse addictive prescription painkillers get them for free from friends or relatives, while drug dealers are a relatively uncommon source for those at highest risk for deadly overdoses, a U.S. government study ...

Deaths from painkiller overdose triple in decade

Nov 01, 2011

The number of overdose deaths from powerful painkillers more than tripled over a decade, the government reported Tuesday - a trend that a U.S. health official called an epidemic, but one that can be stopped.

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments